Catalyst Wire Dossier Catalyst Wire Dossier

Creon IR

pancrelipase · Abbott Laboratories
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Creon IR, covering 2016-02-17 to 2016-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis [Phase 2]

See pricing